BNP Paribas Asset Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
BNP Paribas Asset Management's CDNA Position: Q2 2026 in Review
BNP Paribas Asset Management reduced its CareDx (CDNA) stake by 8.3% in Q2 2026, selling an estimated $2.31K and leaving 1,172 shares worth $33.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1911.
BNP Paribas Asset Management first reported a position in CDNA in Q2 2025 and has held it in 5 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- BNP Paribas Asset Management held 1,172 shares of CareDx worth $33.4K as of Q2 2026.
- BNP Paribas Asset Management sold 106 CareDx shares in Q2 2026, an estimated $2.31K.
- CareDx made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1911 holding.
- BNP Paribas Asset Management first reported a position in CareDx in Q2 2025 and has held it in 5 quarters since.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.